Evidence map›Paper›PMID 33270629›Full record

ArticlePloS one2020

A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy.

Vibha Sharma, Jennifer Jobrack, Wendy Cerenzia, Stephen Tilles, Robert Ryan, Regina Sih-Meynier, Stefan Zeitler, Michael Manning

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Vibha SharmaLydia Becker Institute of Immunology and Inflammation University of Manchester and Royal Manchester Children's Hospital NHS Foundation Trust, Manchester, United Kingdom.
Jennifer JobrackFood Allergy Pros LLC, Chicago, IL, United States of America.
Wendy CerenziaCE Outcomes, Birmingham, AL, United States of America.
Stephen TillesMedical Affairs, Aimmune Therapeutics, Brisbane, CA, United States of America.
Robert RyanAimmune Therapeutics, London, United Kingdom.ORCID 0000-0003-0827-3153
Regina Sih-MeynierMedical Affairs, Aimmune Therapeutics, Brisbane, CA, United States of America.
Stefan ZeitlerAimmune Therapeutics Germany GmbH, Munich, Germany.
Michael ManningMedical Research of Arizona, Scottsdale, AZ, United States of America.ORCID 0000-0003-4455-7356
Food Allergy Research and Education · USHealth Outcomes Solutions (United States) · USRoyal Manchester Children's Hospital · GBScottsdale Research Institute (United States) · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleFood allergy is documented to result in considerable morbidity, negative impact on quality of life, and substantial medical care costs. Although anecdotal data suggest widely varying practices in the diagnosis and management of food allergies, the diversity and relative frequency of these practices have not been documented.

methodsA questionnaire was developed evaluating allergists' management approaches of individuals with peanut allergy (PA) in Germany (DE), France (FR), and the United Kingdom (UK).

resultsHere, we report the survey results from a total of 109 allergists from DE, FR and the UK. They reported to confirm PA at initial diagnosis using skin prick test (≥60%), while allergists from DE and FR reported using allergen-specific IgE testing more (>86%) compared to the UK (<50%). At initial diagnosis, oral food challenge was used less in DE (13%) and FR (14%) and very rarely in the UK (3%) to confirm diagnosis. Recognition of acute reactions, use of adrenaline auto-injectors and allergen avoidance were reported to be discussed with the patient/caregiver at the initial office visit by most allergists (>75%). Half of the responders reported assessing the patient's quality of life. 63% allergists reported retesting for PA resolution at a later date, with 45% allergists indicated to recommend ingestion of a normal serving of peanut regularly upon resolution. Lack of effective PA treatment was reported to be a 'very significant' barrier for optimal PA treatment, with allergists being less than 'moderately familiar' with data from clinical trials testing new treatments options for PA. Lastly, allergists stated that the severity of patient's PA ranked as the most important factor in their decision to recommend oral immunotherapy for PA treatment.

conclusionsThis survey provides essential insights into the practice of allergists and highlights some areas that would inform strategies for education and improving PA healthcare.

Indexed as

AdolescentAllergensAllergistsArachisChildChild, PreschoolEpinephrineEuropeFemaleFood HypersensitivityFranceHumansImmunoglobulin EMalePeanut HypersensitivityPractice Patterns, Physicians'AllergensEpinephrineImmunoglobulin E

Identifiers

PMID33270629
PMCPMC7714149
OpenAlexW3107257380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.